• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    More On BLRX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    BioLineRx, Ltd. (BLRX)

    -NasdaqCM
    2.33 Up 0.03(1.30%) Feb 27, 3:59PM EST
    Add to Portfolio
    Prev Close:2.30
    Open:2.31
    Bid:2.10 x 100
    Ask:N/A
    1y Target Est:9.25
    Beta:1.13
    Next Earnings Date:N/A
    Day's Range:2.30 - 2.37
    52wk Range:1.20 - 3.03
    Volume:219,178
    Avg Vol (3m):346,561
    Market Cap:79.49M
    P/E (ttm):N/A
    EPS (ttm):-0.34
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BLRX

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.45
    Quarterly EPS Est (Dec-14) :-0.24
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioLineRx Ltd., a clinical stage biopharmaceutical development company, is engaged in identifying, in-licensing, and developing therapeutic candidates that address unmet medical needs. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback